TABLE 4.
Mean and median expenditure and range in 2016 dollars by claim service category for Medicaid-enrolled (a) preterm infants (<37 weeks) with birth defects potentially related to Zika virus infection and with no reported birth defects and (b) term infants (≥37 weeks) with birth defects potentially related to Zika virus infection and with no reported birth defects in North Carolina, 2011–2016
(a)
|
Preterm infants with birth defects potentially related to Zika virus infection (n = 180)
|
Preterm infants with no reported birth defects (n = 36,226)
|
Mean expenditure ratio | ||||
Claim service category | Mean (SD) | Median (IQR) | Range | Mean (SD) | Median (IQR) | Range | |
<365 days | |||||||
Total paid | 93,209 (113,458) | 50,669 (78,095) | 21–628,128 | 17,366 (33,406) | 6,877 (13,439) | 0–1,290,659 | 5.4* |
Inpatient facility | 54,916 (80,716) | 28,238 (40,951) | 0–484,195 | 11,402 (24,947) | 3,382 (9,871) | 0–1,176,231 | 4.8* |
Outpatient facility | 2,750 (3,463) | 1,650 (3,480) | 0–18,259 | 494 (1,067) | 161 (509) | 0–36,077 | 5.6* |
Professional/ physician | 19,130 (23,047) | 11,481 (21,219) | 0–188,450 | 3,867 (6,801) | 1,940 (2,679) | 0–167,985 | 4.9* |
Drug/ pharmacy | 6,311 (24,052) | 648 (5,190) | 0–265,077 | 803 (3,587) | 63 (222) | 0–328,699 | 7.9* |
(b)
|
Term infants with birth defects potentially related to Zika virus infection (n = 370)
|
Term infants with no reported birth defects (n = 328,835)
|
Mean expenditure ratio | ||||
Claim service category | Mean (SD) | Median (IQR) | Range | Mean (SD) | Median (IQR) | Range | |
<365 days | |||||||
Total paid | 57,749 (142,272) | 21,016 (43,599) | 84–2,107,324 | 3,384 (8,335) | 2,433 (1,507) | 0–3,191,215 | 17.1* |
Inpatient facility | 31,579 (116,994) | 7,232 (21,565) | 0–1,925,587 | 1,141 (6,034) | 580 (276) | 0–2,580,705 | 27.7* |
Outpatient facility | 3,444 (4,252) | 2,072 (3,941) | 0–26,637 | 316 (771) | 92 (346) | 0–136,750 | 10.9* |
Professional/physician | 9,947 (18,004) | 5,058 (8,307) | 0–188,971 | 1,324 (1,168) | 1,172 (762) | 0–104,180 | 7.5* |
Drug/pharmacy | 4,620 (24,273) | 181 (947) | 0–294,689 | 168 (1,965) | 46 (140) | 0–544,974 | 27.5* |
p < .05 by Wilcoxon-Mann–Whitney test.